Ftse Mib
36.200,72
0,24%
DAX
21.394,93
-0,11%
S&P 500
6.101,24
-0,29%
NASDAQ
19.954,30
-0,50%
Bitcoin
100.477,44
-2,13%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Kymera Therapeutics Inc (KYMR) Kymera Therapeutics Inc (KYMR) Notizie

Kymera Therapeutics Inc

KYMR
44,36
0,13 (0,29%)
25 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/1/202522:02EDGAR2Form 8-K - Current report
14/1/202513:00GLOBEKymera Therapeutics Outlines Key 2025 Objectives and..
13/1/202513:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/1/202513:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202513:00GLOBEKymera Therapeutics to Present at the 43rd Annual J.P...
26/11/202413:00GLOBEKymera Therapeutics to Participate in Upcoming December..
05/11/202413:00GLOBEKymera Therapeutics to Participate in Upcoming November..
31/10/202413:13EDGAR2Form S-3ASR - Automatic shelf registration statement of..
31/10/202412:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202412:40EDGAR2Form 8-K - Current report
31/10/202412:30GLOBEKymera Therapeutics Announces Third Quarter 2024 Financial..
24/10/202413:00GLOBEKymera Therapeutics Announces Dosing of First Participant in..
23/10/202413:15GLOBEKymera Therapeutics to Report Third Quarter 2024 Financial..
23/10/202413:00GLOBEKymera Therapeutics Announces Three Scientific Presentations..
09/10/202413:00GLOBEKymera Therapeutics Announces FDA Clearance of..
25/9/202413:00GLOBEKymera Therapeutics Presents Preclinical Data for KT-621, a..
28/8/202413:00GLOBEKymera Therapeutics to Participate in Upcoming September..
21/8/202417:15GLOBEKymera Therapeutics Announces Closing of Upsized $225..
20/8/202423:24EDGAR2Form 8-K - Current report
20/8/202422:31EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
20/8/202404:45GLOBEKymera Therapeutics Announces Pricing of $225 Million Public..
19/8/202422:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/8/202422:01GLOBEKymera Therapeutics Announces Proposed Public Offering
07/8/202413:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202413:10EDGAR2Form 8-K - Current report
07/8/202413:00GLOBEKymera Therapeutics Announces Second Quarter 2024 Financial..
31/7/202413:00GLOBEKymera Therapeutics to Report Second Quarter 2024 Financial..
17/7/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/7/202422:28EDGAR2Form 144 - Report of proposed sale of securities
15/7/202422:31EDGAR2Form 144 - Report of proposed sale of securities
09/7/202413:00GLOBEKymera Therapeutics to Present in Fireside Chat at the UBS..
09/7/202412:54IHMARKETNEWSBP Slashes Profit Forecast by $700 Million; Morgan Stanley..
08/7/202422:22EDGAR2Form 8-K - Current report
08/7/202422:05GLOBEKymera Announces Expansion of KT-474 (SAR444656) HS and AD..
20/6/202414:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202413:00GLOBEKymera Therapeutics Presents New Clinical Data from the..
01/6/202414:00GLOBEKymera Therapeutics Presents New Clinical Data from Ongoing..
29/5/202413:00GLOBEKymera Therapeutics to Participate in Upcoming June Investor..
23/5/202423:00GLOBEKymera Therapeutics to Present New Clinical Data from..
22/5/202417:20GLOBEKymera Therapeutics Presents New Preclinical Data for..
14/5/202416:00GLOBEKymera Therapeutics to Present New Clinical Data from the..
08/5/202413:00GLOBEKymera Therapeutics to Participate in Upcoming May Investor..
02/5/202413:00GLOBEKymera Therapeutics Announces First Quarter 2024 Financial..
25/4/202413:00GLOBEKymera Therapeutics to Report First Quarter 2024 Financial..
08/4/202413:00GLOBEKymera Therapeutics Announces Scientific Presentations at..
08/3/202416:00GLOBEKymera Therapeutics Presents Preclinical Data for STAT6 and..
05/3/202400:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202400:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202400:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202423:50EDGAR2Form 144 - Report of proposed sale of securities
Apertura: 43,96 Min: 42,95 Max: 44,52
Chiusura: 44,23

La tua Cronologia

NASDAQ
KYMR
Kymera Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network